US 9701623
Di-aliphatic substituted pegylated lipids
granted A61KA61K31/713A61K47/60
Quick answer
US patent 9701623 (Di-aliphatic substituted pegylated lipids) held by Takeda Pharmaceutical Company Limited expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K31/713, A61K47/60, A61K9/1271, A61P